CBNEX | MEDCX | CBNEX / MEDCX | |
Total Expense Ratio | 1.16 | 1.81 | 64% |
Annual Report Gross Expense Ratio | 1.16 | 1.82 | 64% |
Fund Existence | 9 years | 23 years | - |
Gain YTD | 9.327 | 6.364 | 147% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 1000 | 25% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 3.36B | 7.48B | 45% |
Annual Yield % from dividends | 5.49 | 4.89 | 112% |
Returns for 1 year | 5.94 | 6.81 | 87% |
Returns for 3 years | 26.52 | 24.91 | 106% |
Returns for 5 years | 9.99 | 5.25 | 190% |
Returns for 10 years | N/A | 34.38 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
TOTRX | 11.82 | 0.28 | +2.43% |
Transamerica Mid Cap Value Opps R | |||
NCVLX | 12.75 | 0.23 | +1.84% |
Nuance Concentrated Value Institutional | |||
CVTCX | 53.55 | 0.70 | +1.32% |
Calamos Growth & Income C | |||
QGRPX | 19.16 | 0.25 | +1.32% |
UBS US Quality Growth At Rsnbl Prc P | |||
RGBFX | 40.66 | 0.36 | +0.89% |
American Funds Global Balanced R5 |